SlideShare a Scribd company logo
1 of 14
Download to read offline
An Examination of the Strong Start Initiative
Group Prenatal Care (GPC) Model: A Focus
on Clinical Outcomes, Financial
Sustainability, & Cost Variation
Brandon J. Lock
Georgetown University
School of Nursing & Health Studies
Department of Health Systems Administration
HESY 484 - Paying for Health Care: Principles & Innovations
Objective
This paper will examine the impact of the Center for Medicare and Medicaid
Innovation (CMMI) funded enhanced prenatal care model, after two years of funding, to
increase access to care, decrease costs, and increase quality of care. Primary research and
analysis will involve reviewing the preliminary data and evaluations of the Strong Start
initiative, with a specific focus on the group prenatal care (GPC) model. Secondary
research and analysis will involve evaluating the scope of the GPC enhanced prenatal
care model to improve access to effective medical care by reviewing independent
evaluation reports, external data from systematic literature review, financial retrospective
analyses from various payer perspectives, and a GPC financial modeling tool.
Background
The CMMI began funding the Strong Start for Mothers and Newborns initiative in
February of 2013, under section 3021 of the Affordable Care Act (ACA), aiming to
improve maternal and infant outcomes for pregnancies covered by Medicaid and the
Children’s Health Insurance Program (CHIP). The initiative funds three enhanced
prenatal care models: maternity care homes, group prenatal care, and birth centers. In the
first year of the initiative there were 27 awardees and 213 provider sites, across 30 states,
the District of Columbia, and Puerto Rico, with a proposed target of serving up to 80,000
women. The cooperative agreements are over a four-year time frame for a total of $41.4
million. In addition to the awards, CMMI commissioned a five-year independent
evaluation of the initiative to evaluate the implementation and impacts of the initiative on
health delivery, health outcomes, and cost of care by conducting qualitative case studies,
participant-level process evaluations, and impact analysis (CMS, 2014).
Parallel to the launch of this initiative, stakeholders including the Childbirth
Connection, Catalyst for Payment Reform, and the Center for Healthcare Quality and
Payment Reform (CHQPR) commissioned a report in January of 2013 to focus national
attention on the need to better align maternity care payment and quality. As evaluation
data and results became publicly available, interested researchers subsequently conducted
a systematic literature review of the costs of pregnancy in the US to identify the overall
cost of pregnancy, cost of pregnancy-related complications, cost of unintended
pregnancy, cost of planned pregnancy, and cost of pregnancy by facilities in order to
identify key cost drivers. With these studies and reports, and after two years of funding
and implementation, the Strong Start initiative can be more thoroughly examined for its
impact on health delivery, health outcomes, and cost of care. This initiative provides a
unique foundation for understanding the pooling of risk and reimbursement in the context
of improving access to effective medical care for a common and costly medical event
with high cost variance. Additionally, the financial model created by the New York
group, provides a base-line tool and evaluation mechanism for estimating the financial
costs associated with a GPC prenatal care model that could build a supportive case in
favor of the long-term sustainability of GPC, as it relates to this initiative.
Year 1 Evaluation
The independent evaluation of the initiative involves three primary components of
qualitative case studies, participant-level process evaluation, and impact analysis. The
qualitative case studies evaluate the design, implementation, barrier or challenges, and
the success factors. The participant-level process evaluation looks at demographics, risk
characteristics, service use, and outcomes. The impact analysis evaluates rates of
premature birth, low birth weight, Medicaid/CHIP costs through pregnancy and 1st
year
after birth, and variation by model type, awardee, site, and type of services offered and
received. According to the year 1 evaluation, 12 of 27 awardees (44%) are implementing
GPC and 42 of 213 (19.7%) of provider sites offer GPC (CMS, 2014). Demographic
information indicates that the highest number of sites and awardees are in the South,
more than half of the provider sites are in urban or metropolitan areas compared to one
quarter of sites that are in rural areas, and clinical sites operate in a wide variety of
settings including hospitals and health systems, health plans, community-based providers,
Federally Qualified Health Centers (FQHCs), nationally-certified birth centers, Indian
health services clinics, local health departments, and physician groups. Awardees have
set overarching goals of reducing preterm birth, decreasing rates of low birth weight,
decreasing costs of care, increasing outreach to Medicaid/CHIP women, increasing rates
of breastfeeding, and recruiting a range of 50-2000 women in each cohort.
The cross cutting findings, early observations, and emerging issues identified in
the first year offer some hope and significant opportunity for improvement in the areas of
enrollment and implementation. The enrollment process has been time-intensive, due to
several factors including awardee hiring needs, enrollee eligibility screening, staff
training/engagement, and materials development. This has significantly impacted
enrollment, with the number of enrollees being lower than expected at 7,569 women as of
2014. Additionally, there are specific demographic challenges with participants
experiencing high levels of emotional and psychosocial need, within the social
determinants of health framework, and factors such as food insecurity, very low income
or chronic unemployment, unstable housing, lack of reliable transport, unmet medical
needs, and low levels of education about self-care, nutrition, and healthy pregnancy.
Outside of the structural and demographic challenges, there are service delivery
constraints due to Medicaid/CHIP requirements and model sustainability because of the
time-limited nature of the initiative. Similarly, there were several unique challenges
observed during the implementation process such as establishing a consistent and
effective process for identifying and enrolling eligible patients, integrating enhanced
services into existing models of care, retaining women in the program, and complying
with reporting data requirements. An important observation is that the consistency in
implementation practices varies considerably across models and among sites, the nuances
are in the facilitation by different types of providers, the consistency of facilitators, and
the composition of the group. However, whether these variations have an impact on the
experiences and outcomes at this point is still unmeasured and unknown.
With these challenges in mind the recommended strategies for improvement
include developing an “opt out” enrollment process; having more effective messaging
about Strong Start; disseminating best practices to promote supportive and engaged
participant relationships with prenatal care providers and other site staff; willingness to
adapt programs to the specific needs of the site and target population; and the
development of dedicated, skilled, and resourceful program staff. There are some hopeful
results indicating that women participating in this initiative are having lower than average
Cesarean section (C-section) rates of preterm deliveries than the nation as a whole and
that participants are expressing overwhelming satisfaction with their prenatal care. The
future considerations for the initiative are that selection bias remains a concern, the
incremental benefits may be challenging to detect, significant model overlap at several
sites will influence the ability to detect model-specific differences in the impacts, and that
data burden and data collection fatigue may lead to incomplete submissions and poor
quality data.
Year 2 Evaluation
In the second year of evaluation, the proposed target of 80,000 women was
adjusted to 50,000 and many awardees launched or discontinued certain operations and
models, which lead to a 7% decrease in the total number of sites from 213 to 199.
However, the number of sites offering GPC increased from 42 (19.7%) to 54 (27%)
(CMS, 2015). Compared to year one, enrollment accelerated at the end of 2014 and
surpassed 23,000 by the end of Quarter 1 of 2015. With significant enrollment issues
identified in year one, CMMI worked with awardees to provide eligibility adjustments by
eliminating the requirement that women be identified with an additional risk factor for
preterm birth beyond their Medicaid status, allowed women up to 29 weeks’ gestation to
be enrolled, and allowed women with “pending” Medicaid eligibility to be enrolled. As
previously indicated, the increased possibility of selection bias was examined in further
detail and the changes in eligibility have influenced the composition of participants,
however only 7% of women have been enrolled after 28 weeks’ gestation and GPC
appears least likely to have enrolled women in their third trimesters.
In regards to participant demographics, the second year evaluation data indicates
that enrollees are more likely to have had a previous preterm birth than women generally,
which is the strongest predictor of having another preterm delivery. Additionally, the
rates of having had a previous low weight baby are lower than the general population, but
approximately 20% of participants with previous pregnancies reported shorter inter-
pregnancy intervals (less than 18 months), which is another strong predictor of poor birth
outcomes (CMS, 2015). One interesting trend observed in year two is that depression is a
particularly prevalent risk factor, with 25% of participants with this condition being
enrolled in a GPC model. It’s important to recognize that the GPC model’s group
component could be an embedded mechanism for addressing this by helping women
build relationships, facilitating participant mutual support and learning, and providing the
added benefit of knowledge that there are others experiencing many of the same risks,
stress factors, and circumstances that they are experiencing.
The second year evaluation provides a stronger set of quantitative results.
Participants enrolled in GPC received 10 prenatal care visits on average, with visits
lasting approximately 2 hours. With implementation, there are clearer and more
coordinated staffing roles, stronger relationships with obstetrical providers that are
enhancing coordination of service delivery and referrals, and the universal hiring of
administrative staff for data collection and reporting occurred. Results from the Quarter 1
2015 Exit Form Survey show that C-section prevalence among women receiving care
may be lower than the national average and Case Study observations indicate drastic
improvements in prenatal and postpartum visit attendance rates, positive changes in
nutrition/exercise, increased knowledge and confidence about labor and delivery, fewer
unnecessary visits to the ED, and increased access to and use of contraception (CMS,
2015). Lastly, most awardees hope to sustain the programs after the initiative ends and
are planning for the future, with one health-plan based awardee already succeeding in
receiving supplemental reimbursement for GPC in its Medicaid payments.
Synthesis
The National Partnership for Women & Families states that human birth is the
most common operating room procedure (2015). The report The Cost of Having a Baby
in the United States supports and defends this claim stating that, “Routine maternity care
is technology-intensive and expensive and that combined maternal and newborn care is
the most common and costly type of hospital care for all payers (Truven, 2013).”
Therefore, one of the greatest opportunities for improving health care value is in
maternity care because it is something that impacts everyone at the beginning of life and
continues to have an impact on a significant number of women during one or more
episodes of care. Even though this is a well-documented and common procedure,
determining the cost of care for pregnancy is an extremely difficult task. Huynh provides
a relatively recent systematic literature review of the cost of pregnancy in the US and
identifies several different cost-drivers which are inpatient care, pregnancy delivery,
multiple births, complicated C-sections, high-risk pregnancy, preterm birth, low birth
weight, complications due to conditions such as hypertension, diabetes, anemia, and
cancer, and in vitro fertilization (IVF) (2013). While this does not provide a method for
discerning the independent effects of the cost-drivers or the relative importance of each
factor, it does provide a starting point for knowing which variables are contributing to
cost and how they might be incorporated into a financial model.
While childbirth is a major life and population event it’s important to note that the
US birth rate has been declining over the past two decades and that overall costs
associated with pregnancy have been increasing. Interestingly, the two birthing methods,
vaginal or C-section, have distinct and observable payment variations which Childbirth
Connection highlights by showing that the more expensive of the two, the C-section rate,
peaked in 2009 at 32.9% and has since dropped to 32.2% as of 2014 (2015). Because of
these payment variations, it’s important to understand the reasons behind the variation as
well as the declining pregnancy rate and the high C-section rate. The Huynh review
suggests that there are multiple factors that contributing to the differences in pregnancy
rates. Factors including social and behavioral changes in sexual activity, marriage,
divorce, and cohabitation, which affect patterns of intercourse, the social and economic
context of childbearing, and the introduction of contraceptive methods. Childbirth
Connection explains how many assume that the leading factors for the C-section trend are
the belief that more and more women are asking for the procedure that have no medical
rationale, and/or that the number of women who genuinely need a C-section is increasing,
and/or that liability pressure is driving rates (2015). The organization suggests that the
reasons for the high rate are the low priority of enhancing women’s own abilities to give
birth, the side effects of common labor interventions, refusal to offer the informed choice
of vaginal birth, casual attitudes about surgery and variation in professional practice style,
limited awareness of the harms that are more likely with C-sections, professional
expectations for work-life balance, and women’s great trust in their maternity care. While
the organization presents limited quantitative evidence, the proposed reasons are certainly
provocative and should be considered when evaluating the design of an enhanced
prenatal care model such as GPC.
In this complex payment and delivery environment, the Truven Analytics’ report
explains that reducing unwarranted practice variation and the overuse of some
interventions and underuse of others requires a multi-faceted strategy that includes
payment reform, changes in benefit structures, public education, and provider
engagement to successfully drive the needed improvement. This report provides a
reference perspective on the charges and payments for maternal and newborn care by
analyzing the 2010 MarketScan Commercial and Medicaid databases. However, the data
from this report should be considered within the landscape that Huynh provides from the
systematic literature review of 40 pregnancy-cost studies, which shows that 19 (48%)
incorporated hospital billing data that comprised individual hospital data or cost
information from the Agency for Healthcare Research & Quality and Healthcare
Utilization Project (AHRQ-HCUP), 8 (20%) used cost data from managed care programs,
5 (13%) used cost data from medical claims databases, and 3 (8%) used data from
national surveys (2013). Additionally, the heterogeneous nature of the datasets is further
complicated by the mixed distribution of payer perspectives with 3 studies from the
federal government, 2 studies from state governments, 9 studies from commercial payers,
3 studies from institutional, 3 studies from societal, and 10 studies that were
undetermined.
Within this landscape, the Truven study defines cost as, “the amount that
employers or Medicaid managed care plans and Medicaid programs and others pay
hospitals, clinicians, and other service providers (2013).” The report states that the
commercial average total charge for care was ($32,093) for vaginal and ($51,125) for
C-section and that the average total payment for all maternal and newborn care was
($18,329) for vaginal and ($27,866) for C-section. The Medicaid average total charge
for care was ($29,800) for vaginal and ($50,373) for C-section and that the average total
payment for all maternal and newborn care was ($9,131) for vaginal and ($13,590) for
C-section. The major trend is that Commercial and Medicaid payers paid approximately
50% more for C-sections and Commercial payers paid approximately 100% more than
Medicaid. The report breaks down the data further by source of payment, where the
payment went (e.g. facilities or maternity care providers), and by phase of care (e.g.
prenatal, intrapartum, and post-discharge). The key points from the secondary-level of
data analysis, related to GPC, are that primary insurance covers the bulk of the payment
with some cost-sharing for commercially-insured patients (~10-12%) in the form of out-
of-pocket costs and that anywhere from (59-66%) of payment went to facilities and
anywhere from (20-25%) of payment went to maternity care providers, with the rest of
payment flowing to anesthesiology, radiology/imaging, pharmacy and laboratory
services. These are important payment distinctions to make and consider when evaluating
the financial sustainability of GPC based on the flow of payment within the healthcare
continuum. With regards to prenatal care, which is the scope of GPC, commercial
payments for vaginal was ($3,180) and for C-section was ($3,580). Medicaid payments
for vaginal was ($2,405) and for C-section was ($2,589). The final section of the report
provides a landscape view of variability by state with the total commercial maternal care
costs for vaginal ranging from ($10,318 to $16,888) and C-section ranging from ($13,943
to $21,307).
Multiple studies have demonstrated improved prenatal outcomes for GPC
compared to traditional prenatal care measured by rate of prematurity and low birth
weight, fewer C-section deliveries, improved breastfeeding outcomes, and improved
maternal satisfaction with care. The numerous Strong Start initiative sites (54 as of year
2) piloting GPC provide an excellent testbed for examining clinical outcomes as well as
financial costs associated with running a GPC program, which are currently not well
established. A group recently developed a mathematical cost-benefit model for an urban
underserved practice running a GPC program and found that GPC could be financially
sustainable and possibly a net income generator for an outpatient clinic (Rowley, 2016).
The model projects that the adjusted revenue per pregnancy would be $989.93 for
traditional care and $1080.69 for GPC and that cost neutrality for GPC was achieved
when each group enrolled an average of 10.652 women with an enriched staffing model
and 4.801 women when groups were staffed by a single nurse and single clinician. The
study reports that the New York State Department of Health defines adequate prenatal
care as at least seven prenatal visits over the course of pregnancy and that total number of
completed prenatal visits have been shown to exert a positive impact on preterm delivery
rates.
While model projections are promising, it’s important to recognize the necessary
inputs, outputs, limitations, and scalability of the model. The excel model cost projections
for GPC cost and revenue are contingent on variables including group size, payor mix,
patient no-show rate, staffing levels, supply usage, and overhead costs. There is a degree
of robustness to this model, because it allows users to adjust all of these variables and
customize the model to changing situations and needs using ubiquitously available
software. This report provides a template and methodology for doing this, where the team
analyzed 5.5 years of data to determine practice demographics, payor mix, and usual
revenues (Rowley, 2016). The limitations of the model are that it does not include the
most common off-the-shelf GPC solution cost (CenteringPregnancy Network), where
costs of implementation are approximately $20,000 over the first 2 years with ongoing
annual membership of $500 per year and that it assumes that patients who start with the
GPC model will stay in that model of care.
Conclusion
The GPC model, while still in its infancy, provides a strong theoretical construct
and a developing implementation construct for offering an enhanced prenatal care model
that is potentially financially sustainable, could lead to measureable quality
improvements in outcomes, and could reduce price variation through negotiated
reimbursement with payers due to market shifts towards patient satisfaction and quality
of care. The Strong Start initiative has provided funding for three enhanced prenatal care
models and the GPC model experienced a significant increase in awardee site uptake,
despite an overall decrease in total sites going into year 2. As both the initiative’s
evaluation report and financial model indicate, it remains to be seen as to the ability of
the GPC model to address systemic participant-level demographic challenges and the
recruitment and retention requirements to keep costs low and realize project cost savings.
However, the relatively large national volumes associated with pregnancy and prenatal
care indicate significant marketplace demand and the extreme variations in cost indicate
unregulated marketplace supply. Overall, the GPC model offers a strong enhanced
prenatal care model that is outcomes-driven, makes the case for financial sustainability, is
well aligned with market shifts in payment, and could better align market supply and
demand through reduced pregnancy cost-variation.
References:
Rowley, Rebecca A., et al. "Group Prenatal Care: A Financial Perspective." Maternal
and child health journal 20.1 (2016): 1-10.
Huynh, Lynn, et al. "Systematic Literature Review of the Costs of Pregnancy in the US."
PharmacoEconomics 31.11 (2013): 1005-1030.
The Cost of Having a Baby in the United States. Rep. Truven Health Analytics
Marketscan Study, 1 Jan. 2013. Web.
Centers for Medicare & Medicaid Services (CMS). "Strong Start for Mothers and
Newborns Initiative: enhanced prenatal care models." Volume 1 (2014)
Centers for Medicare & Medicaid Services (CMS). "Strong Start for Mothers and
Newborns Initiative: enhanced prenatal care models." Volume 2 (2015).
	
Why	is	the	U.S.	Cesarean	Section	Rate	So	High?	Childbirth	Connection	–	A	Program	of	
the	National	Partnership	for	Women	&	Families.	September	2015.

More Related Content

What's hot

Predicting Patient Interest and Participation in Clinical Trials
Predicting Patient Interest and Participation in Clinical TrialsPredicting Patient Interest and Participation in Clinical Trials
Predicting Patient Interest and Participation in Clinical TrialsNassim Azzi, MBA
 
LCA_PRESENTATION_EXAMPLE
LCA_PRESENTATION_EXAMPLELCA_PRESENTATION_EXAMPLE
LCA_PRESENTATION_EXAMPLETony Fanelli
 
SPOR-PIHCIN Research Day - PIHCIN SPARK
SPOR-PIHCIN Research Day - PIHCIN SPARKSPOR-PIHCIN Research Day - PIHCIN SPARK
SPOR-PIHCIN Research Day - PIHCIN SPARKAlexandra Enns
 
Patient Engagement Presentation - MPN Network Forum April 18, 2017
Patient Engagement Presentation - MPN Network Forum April 18, 2017Patient Engagement Presentation - MPN Network Forum April 18, 2017
Patient Engagement Presentation - MPN Network Forum April 18, 2017Alexandra Enns
 
Coaching employees-to-better-health
Coaching employees-to-better-healthCoaching employees-to-better-health
Coaching employees-to-better-healthGianmarco Brunetti
 
MPN Research Priorities
MPN Research PrioritiesMPN Research Priorities
MPN Research PrioritiesAlexandra Enns
 
Cadth 2015 a5 1 pt engage symp marshall cadth apr 13 2015 present
Cadth 2015 a5 1  pt engage symp marshall cadth apr 13 2015 presentCadth 2015 a5 1  pt engage symp marshall cadth apr 13 2015 present
Cadth 2015 a5 1 pt engage symp marshall cadth apr 13 2015 presentCADTH Symposium
 
Rodriguez COGEN 90cmX120cm-PrintReady
Rodriguez COGEN 90cmX120cm-PrintReadyRodriguez COGEN 90cmX120cm-PrintReady
Rodriguez COGEN 90cmX120cm-PrintReadyKate Lee, MPH
 
Neale Chumbler Regenstrief 2007 Presentation
Neale Chumbler Regenstrief 2007 Presentation Neale Chumbler Regenstrief 2007 Presentation
Neale Chumbler Regenstrief 2007 Presentation ShawnHoke
 
Policy brief presentation
Policy brief presentationPolicy brief presentation
Policy brief presentationbtayman35
 
Marshall Chin Regenstrief Qi Disparities Slides
Marshall Chin Regenstrief Qi Disparities SlidesMarshall Chin Regenstrief Qi Disparities Slides
Marshall Chin Regenstrief Qi Disparities SlidesShawnHoke
 
John Douglas: Chlamydia Prevention in the US - Update from CDC
John Douglas: Chlamydia Prevention in the US - Update from CDCJohn Douglas: Chlamydia Prevention in the US - Update from CDC
John Douglas: Chlamydia Prevention in the US - Update from CDCNational Chlamydia Coalition
 
SAFTINet Overview for EDRC
SAFTINet Overview for EDRCSAFTINet Overview for EDRC
SAFTINet Overview for EDRCMarion Sills
 
Foreman Presentation - 24x36
Foreman Presentation - 24x36Foreman Presentation - 24x36
Foreman Presentation - 24x36Carl Foreman
 
Outcomes pcmh 2010
Outcomes pcmh 2010Outcomes pcmh 2010
Outcomes pcmh 2010Paul Grundy
 
Research Priorities for Differentiated Care
Research Priorities for Differentiated CareResearch Priorities for Differentiated Care
Research Priorities for Differentiated CareHopkinsCFAR
 

What's hot (20)

Predicting Patient Interest and Participation in Clinical Trials
Predicting Patient Interest and Participation in Clinical TrialsPredicting Patient Interest and Participation in Clinical Trials
Predicting Patient Interest and Participation in Clinical Trials
 
LCA_PRESENTATION_EXAMPLE
LCA_PRESENTATION_EXAMPLELCA_PRESENTATION_EXAMPLE
LCA_PRESENTATION_EXAMPLE
 
SPOR-PIHCIN Research Day - PIHCIN SPARK
SPOR-PIHCIN Research Day - PIHCIN SPARKSPOR-PIHCIN Research Day - PIHCIN SPARK
SPOR-PIHCIN Research Day - PIHCIN SPARK
 
Patient Engagement Presentation - MPN Network Forum April 18, 2017
Patient Engagement Presentation - MPN Network Forum April 18, 2017Patient Engagement Presentation - MPN Network Forum April 18, 2017
Patient Engagement Presentation - MPN Network Forum April 18, 2017
 
Coaching employees-to-better-health
Coaching employees-to-better-healthCoaching employees-to-better-health
Coaching employees-to-better-health
 
MPN Research Priorities
MPN Research PrioritiesMPN Research Priorities
MPN Research Priorities
 
Cadth 2015 a5 1 pt engage symp marshall cadth apr 13 2015 present
Cadth 2015 a5 1  pt engage symp marshall cadth apr 13 2015 presentCadth 2015 a5 1  pt engage symp marshall cadth apr 13 2015 present
Cadth 2015 a5 1 pt engage symp marshall cadth apr 13 2015 present
 
Survey_key_points-Care Coordination
Survey_key_points-Care CoordinationSurvey_key_points-Care Coordination
Survey_key_points-Care Coordination
 
Rodriguez COGEN 90cmX120cm-PrintReady
Rodriguez COGEN 90cmX120cm-PrintReadyRodriguez COGEN 90cmX120cm-PrintReady
Rodriguez COGEN 90cmX120cm-PrintReady
 
team-based-care_final_print
team-based-care_final_printteam-based-care_final_print
team-based-care_final_print
 
Neale Chumbler Regenstrief 2007 Presentation
Neale Chumbler Regenstrief 2007 Presentation Neale Chumbler Regenstrief 2007 Presentation
Neale Chumbler Regenstrief 2007 Presentation
 
Policy brief presentation
Policy brief presentationPolicy brief presentation
Policy brief presentation
 
Marshall Chin Regenstrief Qi Disparities Slides
Marshall Chin Regenstrief Qi Disparities SlidesMarshall Chin Regenstrief Qi Disparities Slides
Marshall Chin Regenstrief Qi Disparities Slides
 
Comorbilidades
ComorbilidadesComorbilidades
Comorbilidades
 
John Douglas: Chlamydia Prevention in the US - Update from CDC
John Douglas: Chlamydia Prevention in the US - Update from CDCJohn Douglas: Chlamydia Prevention in the US - Update from CDC
John Douglas: Chlamydia Prevention in the US - Update from CDC
 
SAFTINet Overview for EDRC
SAFTINet Overview for EDRCSAFTINet Overview for EDRC
SAFTINet Overview for EDRC
 
Tinsley
TinsleyTinsley
Tinsley
 
Foreman Presentation - 24x36
Foreman Presentation - 24x36Foreman Presentation - 24x36
Foreman Presentation - 24x36
 
Outcomes pcmh 2010
Outcomes pcmh 2010Outcomes pcmh 2010
Outcomes pcmh 2010
 
Research Priorities for Differentiated Care
Research Priorities for Differentiated CareResearch Priorities for Differentiated Care
Research Priorities for Differentiated Care
 

Viewers also liked

EECS 452 EMG Group (2)
EECS 452 EMG Group (2)EECS 452 EMG Group (2)
EECS 452 EMG Group (2)Angie Zhang
 
Hacking Into Medical Devices
Hacking Into Medical DevicesHacking Into Medical Devices
Hacking Into Medical DevicesJane Wang
 
Advancing Medical Device Interoperability (MDI)
Advancing Medical Device Interoperability (MDI)Advancing Medical Device Interoperability (MDI)
Advancing Medical Device Interoperability (MDI)Brandon Lock
 
Applying Business Analytics & Strategy to Optimize Web-Based Educational Cont...
Applying Business Analytics & Strategy to Optimize Web-Based Educational Cont...Applying Business Analytics & Strategy to Optimize Web-Based Educational Cont...
Applying Business Analytics & Strategy to Optimize Web-Based Educational Cont...Brandon Lock
 
Device interface (090721)
Device interface (090721)Device interface (090721)
Device interface (090721)대갑 김
 
Update on software as a medical device (SaMD)
Update on software as a medical device (SaMD)Update on software as a medical device (SaMD)
Update on software as a medical device (SaMD)TGA Australia
 
Systems Engineering in Medical Devices
Systems Engineering in Medical DevicesSystems Engineering in Medical Devices
Systems Engineering in Medical Deviceschannylaux
 
Medical Device Security: State of the Art -- NoConName, Barcelona, 2011
Medical Device Security:  State of the Art -- NoConName, Barcelona, 2011 Medical Device Security:  State of the Art -- NoConName, Barcelona, 2011
Medical Device Security: State of the Art -- NoConName, Barcelona, 2011 shawn_merdinger
 
Presentation: Data Integrity – an international regulatory perspective
Presentation: Data Integrity – an international regulatory perspectivePresentation: Data Integrity – an international regulatory perspective
Presentation: Data Integrity – an international regulatory perspectiveTGA Australia
 
Capsule Corporate Overview
Capsule Corporate OverviewCapsule Corporate Overview
Capsule Corporate OverviewCapsuleTech
 
Contemporary Medical Device Marketing for the Digital Age
Contemporary Medical Device Marketing for the Digital AgeContemporary Medical Device Marketing for the Digital Age
Contemporary Medical Device Marketing for the Digital AgeJoe Hage
 
Passenger Counting / People Counting Applications and Devices
Passenger Counting / People Counting Applications and DevicesPassenger Counting / People Counting Applications and Devices
Passenger Counting / People Counting Applications and DevicesEurotech
 
Device to Intelligence, IOT and Big Data in Oracle
Device to Intelligence, IOT and Big Data in OracleDevice to Intelligence, IOT and Big Data in Oracle
Device to Intelligence, IOT and Big Data in OracleJunSeok Seo
 
FDA Expectations for Traceability in Device & Diagnostic Design
FDA Expectations for Traceability in Device & Diagnostic DesignFDA Expectations for Traceability in Device & Diagnostic Design
FDA Expectations for Traceability in Device & Diagnostic DesignSeapine Software
 
Systems Engineering and Requirements Management in Medical Device Product Dev...
Systems Engineering and Requirements Management in Medical Device Product Dev...Systems Engineering and Requirements Management in Medical Device Product Dev...
Systems Engineering and Requirements Management in Medical Device Product Dev...UBMCanon
 
Design control FDA requirements
Design control FDA requirementsDesign control FDA requirements
Design control FDA requirementsLatvian University
 
Presentation on data integrity in Pharmaceutical Industry
Presentation on data integrity in Pharmaceutical IndustryPresentation on data integrity in Pharmaceutical Industry
Presentation on data integrity in Pharmaceutical IndustrySathish Vemula
 

Viewers also liked (17)

EECS 452 EMG Group (2)
EECS 452 EMG Group (2)EECS 452 EMG Group (2)
EECS 452 EMG Group (2)
 
Hacking Into Medical Devices
Hacking Into Medical DevicesHacking Into Medical Devices
Hacking Into Medical Devices
 
Advancing Medical Device Interoperability (MDI)
Advancing Medical Device Interoperability (MDI)Advancing Medical Device Interoperability (MDI)
Advancing Medical Device Interoperability (MDI)
 
Applying Business Analytics & Strategy to Optimize Web-Based Educational Cont...
Applying Business Analytics & Strategy to Optimize Web-Based Educational Cont...Applying Business Analytics & Strategy to Optimize Web-Based Educational Cont...
Applying Business Analytics & Strategy to Optimize Web-Based Educational Cont...
 
Device interface (090721)
Device interface (090721)Device interface (090721)
Device interface (090721)
 
Update on software as a medical device (SaMD)
Update on software as a medical device (SaMD)Update on software as a medical device (SaMD)
Update on software as a medical device (SaMD)
 
Systems Engineering in Medical Devices
Systems Engineering in Medical DevicesSystems Engineering in Medical Devices
Systems Engineering in Medical Devices
 
Medical Device Security: State of the Art -- NoConName, Barcelona, 2011
Medical Device Security:  State of the Art -- NoConName, Barcelona, 2011 Medical Device Security:  State of the Art -- NoConName, Barcelona, 2011
Medical Device Security: State of the Art -- NoConName, Barcelona, 2011
 
Presentation: Data Integrity – an international regulatory perspective
Presentation: Data Integrity – an international regulatory perspectivePresentation: Data Integrity – an international regulatory perspective
Presentation: Data Integrity – an international regulatory perspective
 
Capsule Corporate Overview
Capsule Corporate OverviewCapsule Corporate Overview
Capsule Corporate Overview
 
Contemporary Medical Device Marketing for the Digital Age
Contemporary Medical Device Marketing for the Digital AgeContemporary Medical Device Marketing for the Digital Age
Contemporary Medical Device Marketing for the Digital Age
 
Passenger Counting / People Counting Applications and Devices
Passenger Counting / People Counting Applications and DevicesPassenger Counting / People Counting Applications and Devices
Passenger Counting / People Counting Applications and Devices
 
Device to Intelligence, IOT and Big Data in Oracle
Device to Intelligence, IOT and Big Data in OracleDevice to Intelligence, IOT and Big Data in Oracle
Device to Intelligence, IOT and Big Data in Oracle
 
FDA Expectations for Traceability in Device & Diagnostic Design
FDA Expectations for Traceability in Device & Diagnostic DesignFDA Expectations for Traceability in Device & Diagnostic Design
FDA Expectations for Traceability in Device & Diagnostic Design
 
Systems Engineering and Requirements Management in Medical Device Product Dev...
Systems Engineering and Requirements Management in Medical Device Product Dev...Systems Engineering and Requirements Management in Medical Device Product Dev...
Systems Engineering and Requirements Management in Medical Device Product Dev...
 
Design control FDA requirements
Design control FDA requirementsDesign control FDA requirements
Design control FDA requirements
 
Presentation on data integrity in Pharmaceutical Industry
Presentation on data integrity in Pharmaceutical IndustryPresentation on data integrity in Pharmaceutical Industry
Presentation on data integrity in Pharmaceutical Industry
 

Similar to An Examination of the Strong Start Initiative Group Prenatal Care (GPC) Model: A Focus on Clinical Outcomes, Financial Sustainability, & Cost Variation

A Review of Initiatives that Link Provider Payment with Quality Measurement o...
A Review of Initiatives that Link Provider Payment with Quality Measurement o...A Review of Initiatives that Link Provider Payment with Quality Measurement o...
A Review of Initiatives that Link Provider Payment with Quality Measurement o...HFG Project
 
Lannes - Improving health worker performance The patient-perspective
Lannes - Improving health worker performance The patient-perspectiveLannes - Improving health worker performance The patient-perspective
Lannes - Improving health worker performance The patient-perspectivelaurencelannes
 
Assessing a Healthcare Program Policy Evaluation.docx
Assessing a Healthcare Program Policy Evaluation.docxAssessing a Healthcare Program Policy Evaluation.docx
Assessing a Healthcare Program Policy Evaluation.docxwrite22
 
HFABRecommendation2014_15
HFABRecommendation2014_15HFABRecommendation2014_15
HFABRecommendation2014_15Justin Kong
 
HCFOFindingsBriefMarch2014FINAL
HCFOFindingsBriefMarch2014FINALHCFOFindingsBriefMarch2014FINAL
HCFOFindingsBriefMarch2014FINALEmily Blecker
 
The Link between Provider Payment and Quality of Maternal Health Services: A ...
The Link between Provider Payment and Quality of Maternal Health Services: A ...The Link between Provider Payment and Quality of Maternal Health Services: A ...
The Link between Provider Payment and Quality of Maternal Health Services: A ...HFG Project
 
Statistic in Health Care Management Assignment Week 3Case Study.docx
Statistic in Health Care Management Assignment Week 3Case Study.docxStatistic in Health Care Management Assignment Week 3Case Study.docx
Statistic in Health Care Management Assignment Week 3Case Study.docxrafaelaj1
 
Lessons Learned for Strengthening Early Infant Diagnosis of HIV Programs
Lessons Learned for Strengthening Early Infant Diagnosis of HIV ProgramsLessons Learned for Strengthening Early Infant Diagnosis of HIV Programs
Lessons Learned for Strengthening Early Infant Diagnosis of HIV ProgramsHFG Project
 
discusion 1As I mentioned in my introduction, I manage two OBGYN p.docx
discusion 1As I mentioned in my introduction, I manage two OBGYN p.docxdiscusion 1As I mentioned in my introduction, I manage two OBGYN p.docx
discusion 1As I mentioned in my introduction, I manage two OBGYN p.docxowenhall46084
 
Harvard style research paper nursing evidenced based practice
Harvard style research paper   nursing evidenced based practiceHarvard style research paper   nursing evidenced based practice
Harvard style research paper nursing evidenced based practiceCustomEssayOrder
 
Leonard Kingwara publication
Leonard Kingwara publicationLeonard Kingwara publication
Leonard Kingwara publicationLeonard Kingwara
 
Assessment of maternal health intervention programme of delta state, nigeria
Assessment of maternal health intervention programme of delta state, nigeriaAssessment of maternal health intervention programme of delta state, nigeria
Assessment of maternal health intervention programme of delta state, nigeriaAlexander Decker
 
Health Equity Investments: Opportunities and Challenges in 2023
Health Equity Investments: Opportunities and Challenges in 2023Health Equity Investments: Opportunities and Challenges in 2023
Health Equity Investments: Opportunities and Challenges in 2023Health Catalyst
 
1 6Evaluation Plan NameUniversity.docx
1 6Evaluation Plan NameUniversity.docx1 6Evaluation Plan NameUniversity.docx
1 6Evaluation Plan NameUniversity.docxtarifarmarie
 
32 l Nursing2022 l Volume 52, Number 4 www.Nursing2022.com.docx
32 l Nursing2022 l Volume 52, Number 4 www.Nursing2022.com.docx32 l Nursing2022 l Volume 52, Number 4 www.Nursing2022.com.docx
32 l Nursing2022 l Volume 52, Number 4 www.Nursing2022.com.docxstandfordabbot
 

Similar to An Examination of the Strong Start Initiative Group Prenatal Care (GPC) Model: A Focus on Clinical Outcomes, Financial Sustainability, & Cost Variation (20)

A Review of Initiatives that Link Provider Payment with Quality Measurement o...
A Review of Initiatives that Link Provider Payment with Quality Measurement o...A Review of Initiatives that Link Provider Payment with Quality Measurement o...
A Review of Initiatives that Link Provider Payment with Quality Measurement o...
 
Lannes - Improving health worker performance The patient-perspective
Lannes - Improving health worker performance The patient-perspectiveLannes - Improving health worker performance The patient-perspective
Lannes - Improving health worker performance The patient-perspective
 
Assessing a Healthcare Program Policy Evaluation.docx
Assessing a Healthcare Program Policy Evaluation.docxAssessing a Healthcare Program Policy Evaluation.docx
Assessing a Healthcare Program Policy Evaluation.docx
 
HFABRecommendation2014_15
HFABRecommendation2014_15HFABRecommendation2014_15
HFABRecommendation2014_15
 
OGIJ-02-00020
OGIJ-02-00020OGIJ-02-00020
OGIJ-02-00020
 
HCFOFindingsBriefMarch2014FINAL
HCFOFindingsBriefMarch2014FINALHCFOFindingsBriefMarch2014FINAL
HCFOFindingsBriefMarch2014FINAL
 
00.SM2015-Technical Note July 2015- ENG
00.SM2015-Technical Note  July 2015- ENG00.SM2015-Technical Note  July 2015- ENG
00.SM2015-Technical Note July 2015- ENG
 
The Link between Provider Payment and Quality of Maternal Health Services: A ...
The Link between Provider Payment and Quality of Maternal Health Services: A ...The Link between Provider Payment and Quality of Maternal Health Services: A ...
The Link between Provider Payment and Quality of Maternal Health Services: A ...
 
HLST4250Paper (1)
HLST4250Paper (1)HLST4250Paper (1)
HLST4250Paper (1)
 
Statistic in Health Care Management Assignment Week 3Case Study.docx
Statistic in Health Care Management Assignment Week 3Case Study.docxStatistic in Health Care Management Assignment Week 3Case Study.docx
Statistic in Health Care Management Assignment Week 3Case Study.docx
 
Lessons Learned for Strengthening Early Infant Diagnosis of HIV Programs
Lessons Learned for Strengthening Early Infant Diagnosis of HIV ProgramsLessons Learned for Strengthening Early Infant Diagnosis of HIV Programs
Lessons Learned for Strengthening Early Infant Diagnosis of HIV Programs
 
discusion 1As I mentioned in my introduction, I manage two OBGYN p.docx
discusion 1As I mentioned in my introduction, I manage two OBGYN p.docxdiscusion 1As I mentioned in my introduction, I manage two OBGYN p.docx
discusion 1As I mentioned in my introduction, I manage two OBGYN p.docx
 
Harvard style research paper nursing evidenced based practice
Harvard style research paper   nursing evidenced based practiceHarvard style research paper   nursing evidenced based practice
Harvard style research paper nursing evidenced based practice
 
Leonard Kingwara publication
Leonard Kingwara publicationLeonard Kingwara publication
Leonard Kingwara publication
 
Assessment of maternal health intervention programme of delta state, nigeria
Assessment of maternal health intervention programme of delta state, nigeriaAssessment of maternal health intervention programme of delta state, nigeria
Assessment of maternal health intervention programme of delta state, nigeria
 
Health Equity Investments: Opportunities and Challenges in 2023
Health Equity Investments: Opportunities and Challenges in 2023Health Equity Investments: Opportunities and Challenges in 2023
Health Equity Investments: Opportunities and Challenges in 2023
 
1 6Evaluation Plan NameUniversity.docx
1 6Evaluation Plan NameUniversity.docx1 6Evaluation Plan NameUniversity.docx
1 6Evaluation Plan NameUniversity.docx
 
32 l Nursing2022 l Volume 52, Number 4 www.Nursing2022.com.docx
32 l Nursing2022 l Volume 52, Number 4 www.Nursing2022.com.docx32 l Nursing2022 l Volume 52, Number 4 www.Nursing2022.com.docx
32 l Nursing2022 l Volume 52, Number 4 www.Nursing2022.com.docx
 
Epe talk for Supervisors
Epe talk for SupervisorsEpe talk for Supervisors
Epe talk for Supervisors
 
ODH_Treatment_Program_Review
ODH_Treatment_Program_ReviewODH_Treatment_Program_Review
ODH_Treatment_Program_Review
 

Recently uploaded

TEST BANK For Robbins & Kumar Basic Pathology, 11th Edition by Vinay Kumar, A...
TEST BANK For Robbins & Kumar Basic Pathology, 11th Edition by Vinay Kumar, A...TEST BANK For Robbins & Kumar Basic Pathology, 11th Edition by Vinay Kumar, A...
TEST BANK For Robbins & Kumar Basic Pathology, 11th Edition by Vinay Kumar, A...rightmanforbloodline
 
VIP Just Call 9548273370 Lucknow Top Class Call Girls Number | 8630512678 Esc...
VIP Just Call 9548273370 Lucknow Top Class Call Girls Number | 8630512678 Esc...VIP Just Call 9548273370 Lucknow Top Class Call Girls Number | 8630512678 Esc...
VIP Just Call 9548273370 Lucknow Top Class Call Girls Number | 8630512678 Esc...meghakumariji156
 
❤️ Chandigarh Call Girls Service ☎️99158-51334☎️ Escort service in Chandigarh...
❤️ Chandigarh Call Girls Service ☎️99158-51334☎️ Escort service in Chandigarh...❤️ Chandigarh Call Girls Service ☎️99158-51334☎️ Escort service in Chandigarh...
❤️ Chandigarh Call Girls Service ☎️99158-51334☎️ Escort service in Chandigarh...rajveerescorts2022
 
Real Sex Provide In Goa ✂️ Call Girl (9316020077) Call Girl In Goa
Real Sex Provide In Goa ✂️ Call Girl   (9316020077) Call Girl In GoaReal Sex Provide In Goa ✂️ Call Girl   (9316020077) Call Girl In Goa
Real Sex Provide In Goa ✂️ Call Girl (9316020077) Call Girl In GoaReal Sex Provide In Goa
 
TIME FOR ACTION: MAY 2024 Securing A Strong Nursing Workforce for North Carolina
TIME FOR ACTION: MAY 2024 Securing A Strong Nursing Workforce for North CarolinaTIME FOR ACTION: MAY 2024 Securing A Strong Nursing Workforce for North Carolina
TIME FOR ACTION: MAY 2024 Securing A Strong Nursing Workforce for North CarolinaMebane Rash
 
CALCIUM - ELECTROLYTE IMBALANCE (HYPERCALCEMIA & HYPOCALCEMIA).pdf
CALCIUM - ELECTROLYTE IMBALANCE (HYPERCALCEMIA & HYPOCALCEMIA).pdfCALCIUM - ELECTROLYTE IMBALANCE (HYPERCALCEMIA & HYPOCALCEMIA).pdf
CALCIUM - ELECTROLYTE IMBALANCE (HYPERCALCEMIA & HYPOCALCEMIA).pdfDolisha Warbi
 
Making change happen: learning from "positive deviancts"
Making change happen: learning from "positive deviancts"Making change happen: learning from "positive deviancts"
Making change happen: learning from "positive deviancts"HelenBevan4
 
Spauldings classification ppt by Dr C P PRINCE
Spauldings classification ppt by Dr C P PRINCESpauldings classification ppt by Dr C P PRINCE
Spauldings classification ppt by Dr C P PRINCEDR.PRINCE C P
 
MAGNESIUM - ELECTROLYTE IMBALANCE (HYPERMAGNESEMIA & HYPOMAGNESEMIA).pdf
MAGNESIUM - ELECTROLYTE IMBALANCE (HYPERMAGNESEMIA & HYPOMAGNESEMIA).pdfMAGNESIUM - ELECTROLYTE IMBALANCE (HYPERMAGNESEMIA & HYPOMAGNESEMIA).pdf
MAGNESIUM - ELECTROLYTE IMBALANCE (HYPERMAGNESEMIA & HYPOMAGNESEMIA).pdfDolisha Warbi
 
TEST BANK For Little and Falace's Dental Management of the Medically Compromi...
TEST BANK For Little and Falace's Dental Management of the Medically Compromi...TEST BANK For Little and Falace's Dental Management of the Medically Compromi...
TEST BANK For Little and Falace's Dental Management of the Medically Compromi...rightmanforbloodline
 
Leading large scale change: a life at the interface between theory and practice
Leading large scale change: a life at the interface between theory and practiceLeading large scale change: a life at the interface between theory and practice
Leading large scale change: a life at the interface between theory and practiceHelenBevan4
 
Coach Dan Quinn Commanders Feather T Shirts
Coach Dan Quinn Commanders Feather T ShirtsCoach Dan Quinn Commanders Feather T Shirts
Coach Dan Quinn Commanders Feather T Shirtsrahman018755
 
zencortex suppliment-health and benefit (1).pdf
zencortex suppliment-health and benefit (1).pdfzencortex suppliment-health and benefit (1).pdf
zencortex suppliment-health and benefit (1).pdfWOLDIA UNIVERSITY
 
Post marketing surveillance in Japan, legislation and.pptx
Post marketing surveillance in Japan, legislation and.pptxPost marketing surveillance in Japan, legislation and.pptx
Post marketing surveillance in Japan, legislation and.pptxDimple Marathe
 
Test Bank -Medical-Surgical Nursing Concepts for Interprofessional Collaborat...
Test Bank -Medical-Surgical Nursing Concepts for Interprofessional Collaborat...Test Bank -Medical-Surgical Nursing Concepts for Interprofessional Collaborat...
Test Bank -Medical-Surgical Nursing Concepts for Interprofessional Collaborat...rightmanforbloodline
 
RESPIRATORY ALKALOSIS & RESPIRATORY ACIDOSIS.pdf
RESPIRATORY ALKALOSIS & RESPIRATORY ACIDOSIS.pdfRESPIRATORY ALKALOSIS & RESPIRATORY ACIDOSIS.pdf
RESPIRATORY ALKALOSIS & RESPIRATORY ACIDOSIS.pdfDolisha Warbi
 

Recently uploaded (20)

TEST BANK For Robbins & Kumar Basic Pathology, 11th Edition by Vinay Kumar, A...
TEST BANK For Robbins & Kumar Basic Pathology, 11th Edition by Vinay Kumar, A...TEST BANK For Robbins & Kumar Basic Pathology, 11th Edition by Vinay Kumar, A...
TEST BANK For Robbins & Kumar Basic Pathology, 11th Edition by Vinay Kumar, A...
 
VIP Just Call 9548273370 Lucknow Top Class Call Girls Number | 8630512678 Esc...
VIP Just Call 9548273370 Lucknow Top Class Call Girls Number | 8630512678 Esc...VIP Just Call 9548273370 Lucknow Top Class Call Girls Number | 8630512678 Esc...
VIP Just Call 9548273370 Lucknow Top Class Call Girls Number | 8630512678 Esc...
 
OBAT PENGGUGUR KANDUNGAN 081466799220 PIL ABORSI CYTOTEC PELUNTUR JANIN
OBAT PENGGUGUR KANDUNGAN 081466799220 PIL ABORSI CYTOTEC PELUNTUR JANINOBAT PENGGUGUR KANDUNGAN 081466799220 PIL ABORSI CYTOTEC PELUNTUR JANIN
OBAT PENGGUGUR KANDUNGAN 081466799220 PIL ABORSI CYTOTEC PELUNTUR JANIN
 
❤️ Chandigarh Call Girls Service ☎️99158-51334☎️ Escort service in Chandigarh...
❤️ Chandigarh Call Girls Service ☎️99158-51334☎️ Escort service in Chandigarh...❤️ Chandigarh Call Girls Service ☎️99158-51334☎️ Escort service in Chandigarh...
❤️ Chandigarh Call Girls Service ☎️99158-51334☎️ Escort service in Chandigarh...
 
Real Sex Provide In Goa ✂️ Call Girl (9316020077) Call Girl In Goa
Real Sex Provide In Goa ✂️ Call Girl   (9316020077) Call Girl In GoaReal Sex Provide In Goa ✂️ Call Girl   (9316020077) Call Girl In Goa
Real Sex Provide In Goa ✂️ Call Girl (9316020077) Call Girl In Goa
 
TIME FOR ACTION: MAY 2024 Securing A Strong Nursing Workforce for North Carolina
TIME FOR ACTION: MAY 2024 Securing A Strong Nursing Workforce for North CarolinaTIME FOR ACTION: MAY 2024 Securing A Strong Nursing Workforce for North Carolina
TIME FOR ACTION: MAY 2024 Securing A Strong Nursing Workforce for North Carolina
 
CALCIUM - ELECTROLYTE IMBALANCE (HYPERCALCEMIA & HYPOCALCEMIA).pdf
CALCIUM - ELECTROLYTE IMBALANCE (HYPERCALCEMIA & HYPOCALCEMIA).pdfCALCIUM - ELECTROLYTE IMBALANCE (HYPERCALCEMIA & HYPOCALCEMIA).pdf
CALCIUM - ELECTROLYTE IMBALANCE (HYPERCALCEMIA & HYPOCALCEMIA).pdf
 
Making change happen: learning from "positive deviancts"
Making change happen: learning from "positive deviancts"Making change happen: learning from "positive deviancts"
Making change happen: learning from "positive deviancts"
 
Cara Menggugurkan Kandungan Secara Alami 3 Jam Tuntas
Cara Menggugurkan Kandungan Secara Alami 3 Jam TuntasCara Menggugurkan Kandungan Secara Alami 3 Jam Tuntas
Cara Menggugurkan Kandungan Secara Alami 3 Jam Tuntas
 
Spauldings classification ppt by Dr C P PRINCE
Spauldings classification ppt by Dr C P PRINCESpauldings classification ppt by Dr C P PRINCE
Spauldings classification ppt by Dr C P PRINCE
 
MAGNESIUM - ELECTROLYTE IMBALANCE (HYPERMAGNESEMIA & HYPOMAGNESEMIA).pdf
MAGNESIUM - ELECTROLYTE IMBALANCE (HYPERMAGNESEMIA & HYPOMAGNESEMIA).pdfMAGNESIUM - ELECTROLYTE IMBALANCE (HYPERMAGNESEMIA & HYPOMAGNESEMIA).pdf
MAGNESIUM - ELECTROLYTE IMBALANCE (HYPERMAGNESEMIA & HYPOMAGNESEMIA).pdf
 
TEST BANK For Little and Falace's Dental Management of the Medically Compromi...
TEST BANK For Little and Falace's Dental Management of the Medically Compromi...TEST BANK For Little and Falace's Dental Management of the Medically Compromi...
TEST BANK For Little and Falace's Dental Management of the Medically Compromi...
 
@Safe Abortion pills IN Jeddah(+918133066128) Un_wanted kit Buy Jeddah
@Safe Abortion pills IN Jeddah(+918133066128) Un_wanted kit Buy Jeddah@Safe Abortion pills IN Jeddah(+918133066128) Un_wanted kit Buy Jeddah
@Safe Abortion pills IN Jeddah(+918133066128) Un_wanted kit Buy Jeddah
 
Leading large scale change: a life at the interface between theory and practice
Leading large scale change: a life at the interface between theory and practiceLeading large scale change: a life at the interface between theory and practice
Leading large scale change: a life at the interface between theory and practice
 
Coach Dan Quinn Commanders Feather T Shirts
Coach Dan Quinn Commanders Feather T ShirtsCoach Dan Quinn Commanders Feather T Shirts
Coach Dan Quinn Commanders Feather T Shirts
 
zencortex suppliment-health and benefit (1).pdf
zencortex suppliment-health and benefit (1).pdfzencortex suppliment-health and benefit (1).pdf
zencortex suppliment-health and benefit (1).pdf
 
Post marketing surveillance in Japan, legislation and.pptx
Post marketing surveillance in Japan, legislation and.pptxPost marketing surveillance in Japan, legislation and.pptx
Post marketing surveillance in Japan, legislation and.pptx
 
Test Bank -Medical-Surgical Nursing Concepts for Interprofessional Collaborat...
Test Bank -Medical-Surgical Nursing Concepts for Interprofessional Collaborat...Test Bank -Medical-Surgical Nursing Concepts for Interprofessional Collaborat...
Test Bank -Medical-Surgical Nursing Concepts for Interprofessional Collaborat...
 
RESPIRATORY ALKALOSIS & RESPIRATORY ACIDOSIS.pdf
RESPIRATORY ALKALOSIS & RESPIRATORY ACIDOSIS.pdfRESPIRATORY ALKALOSIS & RESPIRATORY ACIDOSIS.pdf
RESPIRATORY ALKALOSIS & RESPIRATORY ACIDOSIS.pdf
 
Obat Penggugur Kandungan Cytotec Dan Gastrul Harga Indomaret
Obat Penggugur Kandungan Cytotec Dan Gastrul Harga IndomaretObat Penggugur Kandungan Cytotec Dan Gastrul Harga Indomaret
Obat Penggugur Kandungan Cytotec Dan Gastrul Harga Indomaret
 

An Examination of the Strong Start Initiative Group Prenatal Care (GPC) Model: A Focus on Clinical Outcomes, Financial Sustainability, & Cost Variation

  • 1. An Examination of the Strong Start Initiative Group Prenatal Care (GPC) Model: A Focus on Clinical Outcomes, Financial Sustainability, & Cost Variation Brandon J. Lock Georgetown University School of Nursing & Health Studies Department of Health Systems Administration HESY 484 - Paying for Health Care: Principles & Innovations
  • 2. Objective This paper will examine the impact of the Center for Medicare and Medicaid Innovation (CMMI) funded enhanced prenatal care model, after two years of funding, to increase access to care, decrease costs, and increase quality of care. Primary research and analysis will involve reviewing the preliminary data and evaluations of the Strong Start initiative, with a specific focus on the group prenatal care (GPC) model. Secondary research and analysis will involve evaluating the scope of the GPC enhanced prenatal care model to improve access to effective medical care by reviewing independent evaluation reports, external data from systematic literature review, financial retrospective analyses from various payer perspectives, and a GPC financial modeling tool. Background The CMMI began funding the Strong Start for Mothers and Newborns initiative in February of 2013, under section 3021 of the Affordable Care Act (ACA), aiming to improve maternal and infant outcomes for pregnancies covered by Medicaid and the Children’s Health Insurance Program (CHIP). The initiative funds three enhanced prenatal care models: maternity care homes, group prenatal care, and birth centers. In the first year of the initiative there were 27 awardees and 213 provider sites, across 30 states, the District of Columbia, and Puerto Rico, with a proposed target of serving up to 80,000 women. The cooperative agreements are over a four-year time frame for a total of $41.4 million. In addition to the awards, CMMI commissioned a five-year independent evaluation of the initiative to evaluate the implementation and impacts of the initiative on health delivery, health outcomes, and cost of care by conducting qualitative case studies, participant-level process evaluations, and impact analysis (CMS, 2014).
  • 3. Parallel to the launch of this initiative, stakeholders including the Childbirth Connection, Catalyst for Payment Reform, and the Center for Healthcare Quality and Payment Reform (CHQPR) commissioned a report in January of 2013 to focus national attention on the need to better align maternity care payment and quality. As evaluation data and results became publicly available, interested researchers subsequently conducted a systematic literature review of the costs of pregnancy in the US to identify the overall cost of pregnancy, cost of pregnancy-related complications, cost of unintended pregnancy, cost of planned pregnancy, and cost of pregnancy by facilities in order to identify key cost drivers. With these studies and reports, and after two years of funding and implementation, the Strong Start initiative can be more thoroughly examined for its impact on health delivery, health outcomes, and cost of care. This initiative provides a unique foundation for understanding the pooling of risk and reimbursement in the context of improving access to effective medical care for a common and costly medical event with high cost variance. Additionally, the financial model created by the New York group, provides a base-line tool and evaluation mechanism for estimating the financial costs associated with a GPC prenatal care model that could build a supportive case in favor of the long-term sustainability of GPC, as it relates to this initiative. Year 1 Evaluation The independent evaluation of the initiative involves three primary components of qualitative case studies, participant-level process evaluation, and impact analysis. The qualitative case studies evaluate the design, implementation, barrier or challenges, and the success factors. The participant-level process evaluation looks at demographics, risk characteristics, service use, and outcomes. The impact analysis evaluates rates of
  • 4. premature birth, low birth weight, Medicaid/CHIP costs through pregnancy and 1st year after birth, and variation by model type, awardee, site, and type of services offered and received. According to the year 1 evaluation, 12 of 27 awardees (44%) are implementing GPC and 42 of 213 (19.7%) of provider sites offer GPC (CMS, 2014). Demographic information indicates that the highest number of sites and awardees are in the South, more than half of the provider sites are in urban or metropolitan areas compared to one quarter of sites that are in rural areas, and clinical sites operate in a wide variety of settings including hospitals and health systems, health plans, community-based providers, Federally Qualified Health Centers (FQHCs), nationally-certified birth centers, Indian health services clinics, local health departments, and physician groups. Awardees have set overarching goals of reducing preterm birth, decreasing rates of low birth weight, decreasing costs of care, increasing outreach to Medicaid/CHIP women, increasing rates of breastfeeding, and recruiting a range of 50-2000 women in each cohort. The cross cutting findings, early observations, and emerging issues identified in the first year offer some hope and significant opportunity for improvement in the areas of enrollment and implementation. The enrollment process has been time-intensive, due to several factors including awardee hiring needs, enrollee eligibility screening, staff training/engagement, and materials development. This has significantly impacted enrollment, with the number of enrollees being lower than expected at 7,569 women as of 2014. Additionally, there are specific demographic challenges with participants experiencing high levels of emotional and psychosocial need, within the social determinants of health framework, and factors such as food insecurity, very low income or chronic unemployment, unstable housing, lack of reliable transport, unmet medical
  • 5. needs, and low levels of education about self-care, nutrition, and healthy pregnancy. Outside of the structural and demographic challenges, there are service delivery constraints due to Medicaid/CHIP requirements and model sustainability because of the time-limited nature of the initiative. Similarly, there were several unique challenges observed during the implementation process such as establishing a consistent and effective process for identifying and enrolling eligible patients, integrating enhanced services into existing models of care, retaining women in the program, and complying with reporting data requirements. An important observation is that the consistency in implementation practices varies considerably across models and among sites, the nuances are in the facilitation by different types of providers, the consistency of facilitators, and the composition of the group. However, whether these variations have an impact on the experiences and outcomes at this point is still unmeasured and unknown. With these challenges in mind the recommended strategies for improvement include developing an “opt out” enrollment process; having more effective messaging about Strong Start; disseminating best practices to promote supportive and engaged participant relationships with prenatal care providers and other site staff; willingness to adapt programs to the specific needs of the site and target population; and the development of dedicated, skilled, and resourceful program staff. There are some hopeful results indicating that women participating in this initiative are having lower than average Cesarean section (C-section) rates of preterm deliveries than the nation as a whole and that participants are expressing overwhelming satisfaction with their prenatal care. The future considerations for the initiative are that selection bias remains a concern, the incremental benefits may be challenging to detect, significant model overlap at several
  • 6. sites will influence the ability to detect model-specific differences in the impacts, and that data burden and data collection fatigue may lead to incomplete submissions and poor quality data. Year 2 Evaluation In the second year of evaluation, the proposed target of 80,000 women was adjusted to 50,000 and many awardees launched or discontinued certain operations and models, which lead to a 7% decrease in the total number of sites from 213 to 199. However, the number of sites offering GPC increased from 42 (19.7%) to 54 (27%) (CMS, 2015). Compared to year one, enrollment accelerated at the end of 2014 and surpassed 23,000 by the end of Quarter 1 of 2015. With significant enrollment issues identified in year one, CMMI worked with awardees to provide eligibility adjustments by eliminating the requirement that women be identified with an additional risk factor for preterm birth beyond their Medicaid status, allowed women up to 29 weeks’ gestation to be enrolled, and allowed women with “pending” Medicaid eligibility to be enrolled. As previously indicated, the increased possibility of selection bias was examined in further detail and the changes in eligibility have influenced the composition of participants, however only 7% of women have been enrolled after 28 weeks’ gestation and GPC appears least likely to have enrolled women in their third trimesters. In regards to participant demographics, the second year evaluation data indicates that enrollees are more likely to have had a previous preterm birth than women generally, which is the strongest predictor of having another preterm delivery. Additionally, the rates of having had a previous low weight baby are lower than the general population, but approximately 20% of participants with previous pregnancies reported shorter inter-
  • 7. pregnancy intervals (less than 18 months), which is another strong predictor of poor birth outcomes (CMS, 2015). One interesting trend observed in year two is that depression is a particularly prevalent risk factor, with 25% of participants with this condition being enrolled in a GPC model. It’s important to recognize that the GPC model’s group component could be an embedded mechanism for addressing this by helping women build relationships, facilitating participant mutual support and learning, and providing the added benefit of knowledge that there are others experiencing many of the same risks, stress factors, and circumstances that they are experiencing. The second year evaluation provides a stronger set of quantitative results. Participants enrolled in GPC received 10 prenatal care visits on average, with visits lasting approximately 2 hours. With implementation, there are clearer and more coordinated staffing roles, stronger relationships with obstetrical providers that are enhancing coordination of service delivery and referrals, and the universal hiring of administrative staff for data collection and reporting occurred. Results from the Quarter 1 2015 Exit Form Survey show that C-section prevalence among women receiving care may be lower than the national average and Case Study observations indicate drastic improvements in prenatal and postpartum visit attendance rates, positive changes in nutrition/exercise, increased knowledge and confidence about labor and delivery, fewer unnecessary visits to the ED, and increased access to and use of contraception (CMS, 2015). Lastly, most awardees hope to sustain the programs after the initiative ends and are planning for the future, with one health-plan based awardee already succeeding in receiving supplemental reimbursement for GPC in its Medicaid payments. Synthesis
  • 8. The National Partnership for Women & Families states that human birth is the most common operating room procedure (2015). The report The Cost of Having a Baby in the United States supports and defends this claim stating that, “Routine maternity care is technology-intensive and expensive and that combined maternal and newborn care is the most common and costly type of hospital care for all payers (Truven, 2013).” Therefore, one of the greatest opportunities for improving health care value is in maternity care because it is something that impacts everyone at the beginning of life and continues to have an impact on a significant number of women during one or more episodes of care. Even though this is a well-documented and common procedure, determining the cost of care for pregnancy is an extremely difficult task. Huynh provides a relatively recent systematic literature review of the cost of pregnancy in the US and identifies several different cost-drivers which are inpatient care, pregnancy delivery, multiple births, complicated C-sections, high-risk pregnancy, preterm birth, low birth weight, complications due to conditions such as hypertension, diabetes, anemia, and cancer, and in vitro fertilization (IVF) (2013). While this does not provide a method for discerning the independent effects of the cost-drivers or the relative importance of each factor, it does provide a starting point for knowing which variables are contributing to cost and how they might be incorporated into a financial model. While childbirth is a major life and population event it’s important to note that the US birth rate has been declining over the past two decades and that overall costs associated with pregnancy have been increasing. Interestingly, the two birthing methods, vaginal or C-section, have distinct and observable payment variations which Childbirth Connection highlights by showing that the more expensive of the two, the C-section rate,
  • 9. peaked in 2009 at 32.9% and has since dropped to 32.2% as of 2014 (2015). Because of these payment variations, it’s important to understand the reasons behind the variation as well as the declining pregnancy rate and the high C-section rate. The Huynh review suggests that there are multiple factors that contributing to the differences in pregnancy rates. Factors including social and behavioral changes in sexual activity, marriage, divorce, and cohabitation, which affect patterns of intercourse, the social and economic context of childbearing, and the introduction of contraceptive methods. Childbirth Connection explains how many assume that the leading factors for the C-section trend are the belief that more and more women are asking for the procedure that have no medical rationale, and/or that the number of women who genuinely need a C-section is increasing, and/or that liability pressure is driving rates (2015). The organization suggests that the reasons for the high rate are the low priority of enhancing women’s own abilities to give birth, the side effects of common labor interventions, refusal to offer the informed choice of vaginal birth, casual attitudes about surgery and variation in professional practice style, limited awareness of the harms that are more likely with C-sections, professional expectations for work-life balance, and women’s great trust in their maternity care. While the organization presents limited quantitative evidence, the proposed reasons are certainly provocative and should be considered when evaluating the design of an enhanced prenatal care model such as GPC. In this complex payment and delivery environment, the Truven Analytics’ report explains that reducing unwarranted practice variation and the overuse of some interventions and underuse of others requires a multi-faceted strategy that includes payment reform, changes in benefit structures, public education, and provider
  • 10. engagement to successfully drive the needed improvement. This report provides a reference perspective on the charges and payments for maternal and newborn care by analyzing the 2010 MarketScan Commercial and Medicaid databases. However, the data from this report should be considered within the landscape that Huynh provides from the systematic literature review of 40 pregnancy-cost studies, which shows that 19 (48%) incorporated hospital billing data that comprised individual hospital data or cost information from the Agency for Healthcare Research & Quality and Healthcare Utilization Project (AHRQ-HCUP), 8 (20%) used cost data from managed care programs, 5 (13%) used cost data from medical claims databases, and 3 (8%) used data from national surveys (2013). Additionally, the heterogeneous nature of the datasets is further complicated by the mixed distribution of payer perspectives with 3 studies from the federal government, 2 studies from state governments, 9 studies from commercial payers, 3 studies from institutional, 3 studies from societal, and 10 studies that were undetermined. Within this landscape, the Truven study defines cost as, “the amount that employers or Medicaid managed care plans and Medicaid programs and others pay hospitals, clinicians, and other service providers (2013).” The report states that the commercial average total charge for care was ($32,093) for vaginal and ($51,125) for C-section and that the average total payment for all maternal and newborn care was ($18,329) for vaginal and ($27,866) for C-section. The Medicaid average total charge for care was ($29,800) for vaginal and ($50,373) for C-section and that the average total payment for all maternal and newborn care was ($9,131) for vaginal and ($13,590) for C-section. The major trend is that Commercial and Medicaid payers paid approximately
  • 11. 50% more for C-sections and Commercial payers paid approximately 100% more than Medicaid. The report breaks down the data further by source of payment, where the payment went (e.g. facilities or maternity care providers), and by phase of care (e.g. prenatal, intrapartum, and post-discharge). The key points from the secondary-level of data analysis, related to GPC, are that primary insurance covers the bulk of the payment with some cost-sharing for commercially-insured patients (~10-12%) in the form of out- of-pocket costs and that anywhere from (59-66%) of payment went to facilities and anywhere from (20-25%) of payment went to maternity care providers, with the rest of payment flowing to anesthesiology, radiology/imaging, pharmacy and laboratory services. These are important payment distinctions to make and consider when evaluating the financial sustainability of GPC based on the flow of payment within the healthcare continuum. With regards to prenatal care, which is the scope of GPC, commercial payments for vaginal was ($3,180) and for C-section was ($3,580). Medicaid payments for vaginal was ($2,405) and for C-section was ($2,589). The final section of the report provides a landscape view of variability by state with the total commercial maternal care costs for vaginal ranging from ($10,318 to $16,888) and C-section ranging from ($13,943 to $21,307). Multiple studies have demonstrated improved prenatal outcomes for GPC compared to traditional prenatal care measured by rate of prematurity and low birth weight, fewer C-section deliveries, improved breastfeeding outcomes, and improved maternal satisfaction with care. The numerous Strong Start initiative sites (54 as of year 2) piloting GPC provide an excellent testbed for examining clinical outcomes as well as financial costs associated with running a GPC program, which are currently not well
  • 12. established. A group recently developed a mathematical cost-benefit model for an urban underserved practice running a GPC program and found that GPC could be financially sustainable and possibly a net income generator for an outpatient clinic (Rowley, 2016). The model projects that the adjusted revenue per pregnancy would be $989.93 for traditional care and $1080.69 for GPC and that cost neutrality for GPC was achieved when each group enrolled an average of 10.652 women with an enriched staffing model and 4.801 women when groups were staffed by a single nurse and single clinician. The study reports that the New York State Department of Health defines adequate prenatal care as at least seven prenatal visits over the course of pregnancy and that total number of completed prenatal visits have been shown to exert a positive impact on preterm delivery rates. While model projections are promising, it’s important to recognize the necessary inputs, outputs, limitations, and scalability of the model. The excel model cost projections for GPC cost and revenue are contingent on variables including group size, payor mix, patient no-show rate, staffing levels, supply usage, and overhead costs. There is a degree of robustness to this model, because it allows users to adjust all of these variables and customize the model to changing situations and needs using ubiquitously available software. This report provides a template and methodology for doing this, where the team analyzed 5.5 years of data to determine practice demographics, payor mix, and usual revenues (Rowley, 2016). The limitations of the model are that it does not include the most common off-the-shelf GPC solution cost (CenteringPregnancy Network), where costs of implementation are approximately $20,000 over the first 2 years with ongoing
  • 13. annual membership of $500 per year and that it assumes that patients who start with the GPC model will stay in that model of care. Conclusion The GPC model, while still in its infancy, provides a strong theoretical construct and a developing implementation construct for offering an enhanced prenatal care model that is potentially financially sustainable, could lead to measureable quality improvements in outcomes, and could reduce price variation through negotiated reimbursement with payers due to market shifts towards patient satisfaction and quality of care. The Strong Start initiative has provided funding for three enhanced prenatal care models and the GPC model experienced a significant increase in awardee site uptake, despite an overall decrease in total sites going into year 2. As both the initiative’s evaluation report and financial model indicate, it remains to be seen as to the ability of the GPC model to address systemic participant-level demographic challenges and the recruitment and retention requirements to keep costs low and realize project cost savings. However, the relatively large national volumes associated with pregnancy and prenatal care indicate significant marketplace demand and the extreme variations in cost indicate unregulated marketplace supply. Overall, the GPC model offers a strong enhanced prenatal care model that is outcomes-driven, makes the case for financial sustainability, is well aligned with market shifts in payment, and could better align market supply and demand through reduced pregnancy cost-variation. References: Rowley, Rebecca A., et al. "Group Prenatal Care: A Financial Perspective." Maternal and child health journal 20.1 (2016): 1-10.
  • 14. Huynh, Lynn, et al. "Systematic Literature Review of the Costs of Pregnancy in the US." PharmacoEconomics 31.11 (2013): 1005-1030. The Cost of Having a Baby in the United States. Rep. Truven Health Analytics Marketscan Study, 1 Jan. 2013. Web. Centers for Medicare & Medicaid Services (CMS). "Strong Start for Mothers and Newborns Initiative: enhanced prenatal care models." Volume 1 (2014) Centers for Medicare & Medicaid Services (CMS). "Strong Start for Mothers and Newborns Initiative: enhanced prenatal care models." Volume 2 (2015). Why is the U.S. Cesarean Section Rate So High? Childbirth Connection – A Program of the National Partnership for Women & Families. September 2015.